Our Mission

Our mission is to significantly decrease incident HIV and HIV-associated infections and to decrease mortality and morbidity due to HIV and HIV-associated infections and co-morbidities among infants, children, adolescents and pregnant/postpartum women.

IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children

Based on data from IMPAACT 2014, the U.S. FDA has approved doravirine (DOR, Pifeltro®) and a fixed-dose combination of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF, Delstrigo®) for treatment of HIV in children weighing 35 kg or greater.  

Adolescents walking down the street

Research Areas

The IMPAACT Network is committed to conducting high quality clinical trials that will advance the prevention and treatment of HIV and its complications for infants, children, adolescents, and pregnant/postpartum women globally. Our research agenda includes four scientific specific aims.

IMPAACT Community Engagement

Community participation and engagement are critical in the conduct of scientific research. There is mutual benefit to communities and researchers when both parties work together throughout the scientific research process. In the IMPAACT Network, community participation occurs throughout the network, community and site levels through various mechanisms that include representation on the network committees, protocols teams and cross network community activities.

Mom with child

Research Sites

IMPAACT is a global network with sites all over the world in 12 countries.

Map of Sites
52 Sites
12 Countries
4 Continents